• Publications
  • Influence
Radioembolization with yttrium‐90 glass microspheres in hepatocellular carcinoma: European experience on safety and long‐term survival
Radioembolization has been demonstrated to allow locoregional therapy of patients with hepatocellular carcinoma not eligible for transarterial chemoembolization or other local therapies. The aim ofExpand
  • 317
  • 18
Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.
CONTEXT Deciding on the appropriate therapy for patients with malignant diseases mandates accurate tumor staging with whole-body coverage. Magnetic resonance imaging (MRI) and a combined modalityExpand
  • 501
  • 15
Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
PURPOSE To determine the accuracy of dual-modality positron emission tomographic (PET)-computed tomographic (CT) imaging, as compared with PET alone and CT alone, in the staging of non-small cellExpand
  • 512
  • 12
Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors.
UNLABELLED This study was implemented to compare the value of PET, CT, and dual-modality PET/CT imaging for assessing gastrointestinal stromal tumor (GIST) response to imatinib therapy. METHODSExpand
  • 320
  • 12
FDG-PET/CT in re-staging of patients with lymphoma
The aim of this study was to evaluate the clinical significance of combined fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) in patients with lymphoma,Expand
  • 228
  • 11
Combined PET/MRI: a new dimension in whole-body oncology imaging?
IntroductionHybrid imaging systems providing morphological and functional data in a single session have been available for oncological imaging for some time. So far, computed tomography (CT) has beenExpand
  • 226
  • 9
Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans.
UNLABELLED This study was performed to evaluate a possible artifact related to the administration of intravascular contrast agent in dual-modality PET/CT imaging. METHODS Thirty oncology patientsExpand
  • 202
  • 8
  • Open Access
Research reporting standards for radioembolization of hepatic malignancies.
Primary Liver Tumors Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver; its incidence is increasing worldwide. It ranks as the sixth most common tumor and third mostExpand
  • 146
  • 8
  • Open Access
Dual-energy-CT of hypervascular liver lesions in patients with HCC: investigation of image quality and sensitivity
ObjectiveTo investigate dual-energy CT of hypervascular liver lesions in patients with HCC.MethodsForty patients with hepatocellular carcinomas were investigated with abdominal dual-energy CT. InExpand
  • 89
  • 8
Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and
PURPOSE To assess the accuracy of positron emission tomography/computed tomography (PET/CT) when staging different malignant diseases. PATIENTS AND METHODS This was a retrospective, blinded,Expand
  • 433
  • 7